← All organizations

Institute of Hematology and Blood Transfusion, Czech Republic

Academic/Hospital

Also known as: Institute of Hematology and Blood Transfusion, Czech Republic

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 23, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (5 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (9)

NCT06765876Lead sponsorEarly Phase 1Oct 23, 2024
NCT05054257Study chairPhase 1Jun 2, 2021
NCT05054257Overall official - principal investigatorPhase 1Jun 2, 2021
NCT05054257Lead sponsorPhase 1Jun 2, 2021
NCT04554459Overall official - principal investigatorPhase 2Oct 30, 2020
NCT04554459Lead sponsorPhase 2Oct 30, 2020
NCT04554485Overall official - principal investigatorPhase 2May 9, 2019
NCT04554485Lead sponsorPhase 2May 9, 2019
NCT01375868Sponsor investigatorPhase 3Oct 1, 2011

Details

Last known activity: Oct 23, 2024